This dataset contains gene and pathway mutation scores for 5,805 primary tumors from 23 different cancer types from The Cancer Genome Atlas (TCGA). Gene mutation scores of 2,219 cancer-associated genes were calculated by normalizing the number of non-silent mutations in a gene (obtained from .maf files from TCGA) by the gene's length. We used SAMBAR (Subtyping Agglomerated Mutations By Annotation Relations) to calculate pathway mutation scores. In short, SAMBAR takes the sum of mutation scores of all genes belonging to a biological pathway and then corrects these scores for the pathway's gene set size and the number of times a gene is represented in the complete set of pathways. Please see our publication in the British Journal of Cancer f...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Jan-11-2021 Two types of datasets for each cancer type are provided as follows: Varscan called som...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...
This dataset contains gene and pathway mutation scores for 5,805 primary tumors from 23 different ca...
Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of c...
Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
Driver mutations are the genetic variants responsible for oncogenesis, but how specific somatic muta...
All somatic mutations are annotated using OncoKB to determine predicted oncogenecity. Projects are o...
Copyright © 2014 Hai-Tao Li et al. This is an open access article distributed under the Creative Com...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Jan-11-2021 Two types of datasets for each cancer type are provided as follows: Varscan called som...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...
This dataset contains gene and pathway mutation scores for 5,805 primary tumors from 23 different ca...
Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of c...
Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dram...
Driver mutations are the genetic variants responsible for oncogenesis, but how specific somatic muta...
All somatic mutations are annotated using OncoKB to determine predicted oncogenecity. Projects are o...
Copyright © 2014 Hai-Tao Li et al. This is an open access article distributed under the Creative Com...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Jan-11-2021 Two types of datasets for each cancer type are provided as follows: Varscan called som...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...